Minor leaguers Francisco Rivero and Raudi Perez suspended following positive drug tests
NEW YORK (AP) — Washington Nationals catcher Francisco Rivero and free agent pitcher Raudi Perez were suspended for 56 games each Friday following positive tests for a performance-enhancing substance under baseball's minor league drug programs.
Both were disciplined following positive tests for Stanozolol, Rivero under the minor league program and Perez under the program for minor leaguers assigned outside of the U.S. and Canada.
Rivero, 18, signed with the Nationals in July and has not played in any minor league games.
You must be a member to read this story.
Join our family of readers starting at $5 for your first month and support local, unbiased journalism.
Click here to see your options for becoming a subscriber.
Register to comment
Click here create a free account for posting comments.
Note that free accounts do not include access to premium content on this site.
I am anchor
Minor leaguers Francisco Rivero and Raudi Perez suspended following positive drug tests
Posted
NEW YORK (AP) — Washington Nationals catcher Francisco Rivero and free agent pitcher Raudi Perez were suspended for 56 games each Friday following positive tests for a performance-enhancing substance under baseball's minor league drug programs.
Both were disciplined following positive tests for Stanozolol, Rivero under the minor league program and Perez under the program for minor leaguers assigned outside of the U.S. and Canada.
Rivero, 18, signed with the Nationals in July and has not played in any minor league games.
Perez, 19, signed with the Padres in January for a $25,000 bonus and was 0-4 with a 7.09 ERA and one save in six starts and eight relief appearances in the Dominican Summer League. He was released on Sept. 10, and his suspension will start when he signs with a major league organization.
Thirteen players have been disciplined this year for a drug violation, including two under the major league drug agreement.
Comments
No comments on this item Please log in to comment by clicking here